O N THE
MIT Sloan School of Management
The pharmaceutical industry is global, dynamic and successful. It plays a major role in translating scientific discovery to improved healthcare. The industry is evolving continuously in the face of an elucidation of the molecular basis of disease, compliance with regulations and the demands of healthcare cost containment. A better understanding of this industry, its structure, technology and the determinants of its competitiveness should help to strengthen it and assure its future success.
The Program on the Pharmaceutical Industry (POPI) was established in 1991 primarily to promote research and educational activities on issues related to competitiveness, performance and productivity in the pharmaceutical field. The Progam is funded by a major grant from the Alfred P. Sloan Foundation.
This multidisciplinary research program is led by faculty
from the MIT Schools of Science, Engineering, Humanities and Social Sciences,
and Management. Participating faculty and graduate students include those
with expertise in the fields of biology, chemistry, chemical engineering,
economics, medicine, and the management sciences.
|We seek to:||
For more information, comments, or suggestions contact
Sloan School of